Table 2.

Antimicrobial activity of the trehalose lipid produced by R. fascians BD8 against pathogenic microorganisms.

Microorganisms	Growth inhibition (%)
	Trehalose lipid concentration (mg mL−1)
	0.500	0.250	0.200	0.150	0.075	0.035
Enterococcus hirae ATCC 10541	32 ± 0.27	31 ± 0.17	27 ± 0.24	27 ± 0.07	12 ± 0.32	4 ± 0.04
Enterococcus faecalis JA/3	34 ± 0.14	26 ± 0.21	21 ± 0.51	14 ± 0.07	4 ± 0.09	3 ± 0.07
Enterococcus faecalis ATCC 29212	15 ± 0.03	13 ± 0.17	12 ± 0.09	6 ± 0.07	5 ± 0.06	0 ± 0.28
Staphylococcus epidermidis KCTC 1917	14 ± 0.03	10 ± 0.12	8 ± 0.37	4 ± 0.07	2 ± 0.47	2 ± 0.23
Escherichia coli 17-2	25 ± 0.09	24 ± 0.12	20 ± 0.23	6 ± 0.07	4 ± 0.04	3 ± 0.21
Escherichia coli ATCC 10536	25 ± 0.37	21 ± 0.13	18 ± 0.19	10 ± 0.17	49 ± 0.23	3 ± 0.57
Escherichia coli ATCC 25922	11 ± 0.21	9 ± 0.17	6 ± 0.24	5 ± 0.11	2 ± 0.23	2 ± 0.31
Proteus vulgaris ATCC 27973	89 ± 0.32	61 ± 0.12	48 ± 0.14	37 ± 0.51	22 ± 0.47	9 ± 0.17
Proteus mirabilis ATCC 21100	27 ± 0.21	25 ± 0.15	19 ± 0.02	17 ± 0.07	11 ± 0.05	0 ± 0.29
Vibrio harveyi ATCC 14126	95 ± 0.47	72 ± 0.13	54 ± 0.09	33 ± 0.07	21 ± 0.23	11 ± 0.04
Candida albicans ATCC 10231	30 ± 0.47	27 ± 0.31	19 ± 0.08	14 ± 0.07	10 ± 0.03	9 ± 0.27
Candida albicans SC5314	7 ± 0.53	7 ± 0.37	5 ± 0.17	3 ± 0.07	1 ± 0.47	0 ± 0.41

The results represent the average of triplicate experiments ± SD.